DefEYE
Pre-clinicalDefEYE™ delivers innovative ophthalmologic solutions like BIOVANCE® 3L Ocular, the only decellularized basement membrane for ocular surface disease and surgery.
Founded
2020
Focus
OphthalmologyMedical Devices
About
DefEYE™ delivers innovative ophthalmologic solutions like BIOVANCE® 3L Ocular, the only decellularized basement membrane for ocular surface disease and surgery.
Company Info
TypePrivate
Founded2020
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile